⁠6. Glasses on: Assessing Cognitive Footprint with Virtual Reality⁠ episode artwork

EPISODE · Oct 24, 2023 · 25 MIN

⁠6. Glasses on: Assessing Cognitive Footprint with Virtual Reality⁠

from NeuroCentury · host Paweł Świeboda

In this episode of NeuroCentury, Paweł Świeboda talks to Amir Bozorgzadeh, Co-Founder and CEO of Virtuleap, a company that works on addressing mental disorders, cognitive illnesses and learning challenges using Virtual Reality (VR). Paweł and Amir saw each other a few days ago at the Neuro Summit, organized by Broadreach Global and hosted by the Champalimaud Foundation, where Amir won the start-up pitch competition in Lisbon in a tough competition of over a dozen shortlisted companies. The main current product of Virtuleap is EnhancedVR, a library of cognitive exercises to examine and train cognitive skills. In collaboration with Roche, the company is now working on a new product, called CogniclearVR, which it aims to make available by the end of the year. Its focus will be on cognitive decline. The conversation covers incredible progress of VR and what it means for diagnostic and therapeutic application, how VR assesses cognitive performance, what treasure trove of high quality and multisensory data is created as a result. Paweł and Amir discuss the academic underpinnings of Virtuleap’s product development as well as the medical validation methods. Finally, they look into challenges to rollout and Virtuleap’s business model. #neurocentury #brain #virtuleap #VR #virtualreality ________________ neurocentury.com Music for the NeuroCentury podcast is composed by Rafał Kulczycki

In this episode of NeuroCentury, Paweł Świeboda talks to Amir Bozorgzadeh, Co-Founder and CEO of Virtuleap, a company that works on addressing mental disorders, cognitive illnesses and learning challenges using Virtual Reality (VR). Paweł and Amir saw each other a few days ago at the Neuro Summit, organized by Broadreach Global and hosted by the Champalimaud Foundation, where Amir won the start-up pitch competition in Lisbon in a tough competition of over a dozen shortlisted companies. The main current product of Virtuleap is EnhancedVR, a library of cognitive exercises to examine and train cognitive skills. In collaboration with Roche, the company is now working on a new product, called CogniclearVR, which it aims to make available by the end of the year. Its focus will be on cognitive decline. The conversation covers incredible progress of VR and what it means for diagnostic and therapeutic application, how VR assesses cognitive performance, what treasure trove of high quality and multisensory data is created as a result. Paweł and Amir discuss the academic underpinnings of Virtuleap’s product development as well as the medical validation methods. Finally, they look into challenges to rollout and Virtuleap’s business model. #neurocentury #brain #virtuleap #VR #virtualreality ________________ neurocentury.com Music for the NeuroCentury podcast is composed by Rafał Kulczycki

NOW PLAYING

⁠6. Glasses on: Assessing Cognitive Footprint with Virtual Reality⁠

0:00 25:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of NeuroCentury?

This episode is 25 minutes long.

When was this NeuroCentury episode published?

This episode was published on October 24, 2023.

What is this episode about?

In this episode of NeuroCentury, Paweł Świeboda talks to Amir Bozorgzadeh, Co-Founder and CEO of Virtuleap, a company that works on addressing mental disorders, cognitive illnesses and learning challenges using Virtual Reality (VR). Paweł and Amir...

Can I download this NeuroCentury episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!